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Abstract
The parasitic mite Varroa destructor has a significant worldwide impact on bee colony
health. In the absence of control measures, parasitized colonies invariably collapse within 3
years. The synthetic pyrethroids tau-fluvalinate and flumethrin have proven very effective at
managing this mite within apiaries, but intensive control programs based mainly on one
active ingredient have led to many reports of pyrethroid resistance. In Europe, a modifica-
tion of leucine to valine at position 925 (L925V) of the V. destructor voltage-gated sodium
channel was correlated with resistance, the mutation being found at high frequency exclu-
sively in hives with a recent history of pyrethroid treatment. Here, we identify two novel
mutations, L925M and L925I, in tau-fluvalinate resistant V. destructor collected at seven
sites across Florida and Georgia in the Southeastern region of the USA. Using a multi-
plexed TaqMan1 allelic discrimination assay, these mutations were found to be present in
98% of the mites surviving tau-fluvalinate treatment. The mutations were also found in 45%
of the non-treated mites, suggesting a high potential for resistance evolution if selection
pressure is applied. The results from a more extensive monitoring programme, using the
Taqman1 assay described here, would clearly help beekeepers with their decision making
as to when to include or exclude pyrethroid control products and thereby facilitate more
effective mite management programmes.
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Introduction
The ectoparasitic mite Varroa destructor Anderson and Trueman (Arachnida: Acari: Varroi-
dae) causes severe damage to colonies of the Western honey bee (Apis mellifera L.) in many
countries worldwide. It is considered to be one of the most important problems for modern
apiculture and a key factor leading to the high annual losses of honey bee colonies in recent
years [1], posing a serious risk for pollination. In the USA alone, the economic value of crop
pollination contributed by A.mellifera is estimated to be more than 17 billion USD per year
[2], while on a global scale the total value has been estimated to be 153 billion euros per
annum, representing 9.5% of the world’s agricultural food production [3]. Varroa destructor
causes direct damage to bees by feeding on the haemolymph of immature and adult bees, and it
also serves as a vector for several bee viruses that contribute to a progressive decline of bee colo-
nies [4–6]. In the absence of an effective control program, parasitized colonies will usually col-
lapse in less than 3 years.
Currently, there is a wide array of chemotherapeutic, mechanical, cultural and behavioural
management methods available for controlling the parasite (for review see [1]). However,
many beekeepers tend to rely exclusively on a few active ingredients, with the synthetic pyre-
throids tau-fluvalinate and flumethrin being amongst the most popular varroacides due to
their relative low toxicity towards bees, ease of application and high efficacy, eliminating up to
98% of susceptible mites from bee colonies [7]. The application of tau-fluvalinate-based formu-
lations such as Apistan1 was successful for many years in controlling V. destructor levels
within apiaries; however, since the mid-1990s therapeutic failures associated with the evolution
of V. destructor resistance to pyrethroids have been widely reported [8–17]. Similar resistance
evolution has been observed in a wide range of agricultural, veterinary and public health pests
where pyrethroids, with their high arthropod selectivity, low mammalian toxicity and limited
environment persistence, have likewise been used intensively [18]. Some of these cases have
been attributed to alterations in the expression of certain detoxification enzymes [19], but the
most common mechanism of resistance is the substitution of key residues within the voltage-
gated sodium channel (VGSC), the major target site for pyrethroids [20, 21].
Recent studies have reported one particular amino acid substitution (L925V) as being asso-
ciated with the resistance of V. destructor to tau-fluvalinate in samples collected from several
locations in Central/ Southern England [22] and in the Czech Republic [23]. This leucine to
valine substitution at amino acid position 925 of the VGSC, is located within transmembrane
helix S5 of channel domain II (IIS5) that forms one side of a hydrophobic pocket, proposed to
be the major binding site of pyrethroids within the channel protein [24]. This region of the
channel, along with the IIS4-IIS5 linker and IIIS6 helix that also contribute to the binding
pocket, contains a number of residues where mutations are known to give strong (so-called
super-kdr) resistance to pyrethroids. These include at methionine 918 (M918T,L,V,I), leucine
925 (L925I, V), threonine 929 (T929I,C,V,N), leucine 932 (L932F), phenylalanine 1534
(F1534C) and phenylalanine 1538 (F1538I) (for review see [20]). Although other mutations
have been reported from pyrethroid resistant V. destructor populations collected in Korea
and the USA [14, 16], these polymorphisms do not map to regions of the channel that have
been implicated in pyrethroid binding and their role in conferring resistance, if any, is not
known.
In this paper, we report the identification of two alternative amino acid substitutions,
L925M and L925I, in the VGSC of populations of V. destructor originating from seven different
locations across the Southeastern USA. All of the V. destructor in these samples survived treat-
ment with tau-fluvalinate applied at recommended field rates, with one or both of the muta-
tions found in 98% of the resistant mites.
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Material and Methods
Ethics statement
The samples (adult mites) used in this study were voluntarily provided by individual beekeep-
ers knowing that the results would be used for a scientific publication.
Varroa destructor
Honey bees were collected from managed honey bee colonies maintained by part time (50–249
colonies) or commercial (>250 colonies) beekeepers across seven different locations in the
Southeastern USA between April and June 2014. The colonies were managed in Langstroth-
style hives and composed of at least one full-depth Langstroth brood chamber, with additional
supers added as management dictated. All colonies were managed according to practices typi-
cal of beekeeping in the region.
Approximately 3,000–5,000 bees from each of 6 colonies per location were collected from
open brood frames within the brood chamber, shaken into screened plastic chambers (bee-bus.
com) and transported to the Bee Biology Research Unit at the University of Florida (Gaines-
ville, FL). The participating beekeepers did not disclose the varroacide treatment history of the
colonies; however, none of the colonies had been treated within three months prior to bee
collection.
At Gainesville, each screened chamber containing bees from a single colony received 100
mL of 50% (w/v) sucrose solution daily for a period of three days. For screened chambers from
each location, three chambers did not receive any varroacide (negative control) and three
chambers were treated with a new ¼ strip (12.25 × 1.45 cm) of Apistan (tau-fluvalinate) daily
for three days (the used strips were removed and discarded after 24 hours, being replaced by an
unused strip). The ¼ strip size per 3,000–5000 bees per chamber was chosen as the approxi-
mate labelled rate for a whole-colony treatment based upon the assumption that 40,000 bees
per colony are treated with the label rate of two strips. During treatment, mites killed or dis-
lodged by the treatment fell through the bottom of the screened chambers and were collected/
counted. These were considered susceptible to the tau-fluvalinate treatment. All V. destructor
remaining on the adult bees throughout the treatment period were considered tolerant of, or
resistant to, the treatment. All chambers, including bees, were placed in a freezer at -20°C at
the end of the three-day treatment period.
Varroa destructor that had survived the Apistan treatment were recovered following a stan-
dard method with some modifications [25]. Briefly, the frozen host bees were placed into a
bucket containing 3 L of warm (~50°C), soapy water and stirred for two minutes to dislodge
the mites from the bees. The mixture was then poured through a double sieve and washed with
a stream of water for a period of 30 seconds. The V. destructor were quantified, placed into a
1.5mL Eppendorf tube, and immediately stored at -80°C for analysis (Table 1). V. destructor
from at least one untreated control sample were analysed from each location. Not all of the
tau-fluvalinate-treated samples had surviving mites and therefore these samples did not
undergo subsequent molecular analysis.
TaqMan1 diagnostic assays
The assays used genomic DNA extracted from individual adult V. destructor by an alkaline
hydrolysis method as described previously [22] and stored at -20°C. Primers and probes for the
TaqMan1 assays were designed against gene sequences flanking the L925 residue of the V.
destructor VGSC (Accession KC152655) (Fig 1) using Primer Express™ Software v.2.0 (Life
Technologies). Primers Vd_L925V_F (5’-CCAAGTCATGGCCAACGTT-3’) forward and
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PLOSONE | DOI:10.1371/journal.pone.0155332 May 18, 2016 3 / 10
Vd_L925V_R (5’-AAGATGATAATTCCCAACACAAAGG-3’) reverse, were standard oligo-
nucleotides with no modification and have been used previously in similar assays to detect
L925V in European mite samples [22]. Probe Vd_L925_V (5’-TTACCCAGAGCTCC-3’)
was labelled with VIC1 at the 5’ end for detection of the wild-type allele (L925), probe
Vd_L925V_M (5’-TTACCCAcAGCTCCT-3’) was labelled with 6-FAM™ for detection of the
L925V mutation, probe Vd_L925I_M (5’-AGGTTACCtAtAGCTCC-3’) was also labelled with
6-FAM™ for detection of the L925I mutation and probe Vd_L925M_N (5’-TTACCCAtAGCT
CCTATC-3’) was labelled with NED1 for detection of the L925M mutation. Changes to the
wild-type sequence are indicated in lower case in the probe sequences. A 3’ non-fluorescent
quencher and a minor groove binder (MGB) were added to each probe. The MGB increases
the Tm between matched and mismatched probes and improves the accuracy of allele discrimi-
nation [26]. TaqMan1 assays were run on an ABI 7900HT Fast Real-Time PCR System
(Applied Biosystems). The assay mixture contained 1.5 μl genomic DNA, 7.5 μl of 2x Sensi-
FAST™ probe Hi-Rox Mix (Bioline Reagents Ltd), 0.9 μM each primer and 0.2μM each probe,
in a total reaction volume of 15 μl. After optimization, temperature cycling conditions were set
as follows: 2 min at 50°C, 10 min at 95°C followed by 40 cycles of 15 s at 95°C and 45 s at 60°C
for reactions with probes Vd_L925_V and Vd_L925V_M or 62°C for reactions with probes
Table 1. Genotyping results for individual V. destructor collected in seven locations in the Southeastern USA using the TaqMan1 allelic discrimi-
nation assay.
Location1 Sample
Name2
Collected
mites3
HOM
L9254
HOM
I925
HOM
M925
HET L925/
I925
HET L925/
M925
HET M925/
I925
Total
Analysed5
Dunnellon, FL Treated_1 16 0 16 0 0 0 0 16
Treated_3 8 1 7 0 0 0 0 8
Control_1 30 15 3 4 0 2 0 24
Control_2 30 6 0 2 0 0 0 8
Micanopy, FL Treated_2 16 0 12 1 0 0 2 15
Control_3 30 19 1 3 2 1 0 26
Fort Myers,
FL
Treated_1 15 0 6 2 0 0 0 8
Treated_2 22 1 11 5 0 0 1 18
Control_2 30 11 1 9 0 4 0 25
Trenton, FL Treated_1 5 0 3 0 0 0 2 5
Treated_2 3 0 2 0 0 0 0 2
Treated_3 2 0 1 1 0 0 0 2
Control_2 19 12 0 4 1 0 0 17
Kissimmee,
FL
Treated_1 14 0 11 0 0 0 0 11
Control_2 30 11 8 3 1 2 0 25
Chipley, FL Treated_1 7 0 4 0 0 0 0 4
Treated_3 3 0 1 0 0 0 1 2
Control_1 25 4 6 2 3 1 0 16
Sparta, GA Control_2 25 13 5 6 1 0 0 25
1. Location where sample was collected.
2. Treated: Mites surviving three-day treatment with tau-ﬂuvalinate. Control: mites from the same location but collected from chambers not-treated with
tau-ﬂuvalinate.
3. Total number of Varroa collected per sample.
4. Number of mites from each genotype detected in the sample. HOM: Homozygous HET: Heterozygous. L925: wild-type allele, others are mutants.
5. Total number of mites analysed.
doi:10.1371/journal.pone.0155332.t001
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Vd_L925_V, Vd_L925I_M and Vd_L925M_N. The increase in VIC1 (538 nm excitation and
554 nm emission), 6-FAM™ (494 nm excitation and 518 emission) and NED1 (546 nm excita-
tion and 575 emission) fluorescence was monitored in real time by acquiring each cycle on the
relevant filter of the ABI 7900HT.
Analysis of sequences encoding Domain II of V. destructor VGSC
Genomic DNA from at least 2 individuals per sample was used as a template to PCR-amplify
fragments covering the relevant region of domain II (Fig 1) following a two-step nested PCR
strategy [27]. For the primary amplification (PCR1), the primers were 1457iF (5’-GCTACGT
CGCTGTATCTCCC-3’) and 1973iR (5’-GCTGTTGTTACCGTGGAGCA-3’) and for the sec-
ondary amplification (PCR2), the primers were 1479iF (5’-ACTCTTTCTCCCTCCCTCCC-3’)
and 1963iR (5’-CCGTGGAGCAAGTTTTGACC-3’). For each amplification, the reaction mix-
ture contained 0.4 μM of each primer, 15 μl of DreamTaq Green PCR Master Mix (2×)
(Thermo Scientific), 12 μl of distilled water and 1 μl of genomic DNA (or PCR 1) to a final vol-
ume of 30 μl. Cycling conditions were: 94°C for 1 min followed by 35 cycles of 94°C for 20 s,
61°C for 20 s and 72°C for 45 s, and final extension at 72°C for 5 min. The PCR fragments were
precipitated with ethanol and direct sequenced (Eurofins MWGOperon, Germany) using the
primers 1481iF (5’-TCTTTCTCCCTCCCTCCCTC-3’) and 1957iR (5’-AGCAAGTTTTGA
CCTTCGCC-3’). All primers were designed and the sequences analysed using Geneious soft-
ware (Version 8.1, http://www.geneious.com/).
Fig 1. Intron-exon-intron section of the V. destructor VGSC Domain II. Section including the linker between transmembrane segments 4 and 5
(DomII_S4-S5) and the transmembrane segment 5 (IIS5) [in magenta]. Intron [light grey] and exon regions [dark grey], as well as the annealing positions for
primers [green] and TaqMan1 probes [red] are shown. Numbering corresponds to that in Accession KC152655. The position of the residue 925 of the
channel protein is highlighted in blue.
doi:10.1371/journal.pone.0155332.g001
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Results
TaqMan1 allelic discrimination assays designed to detect the L925V mutation that was previ-
ously described in pyrethroid-resistant V. destructor samples collected in Central/Southern
England [22] gave negative results for the resistant V. destructor samples collected from across
the Southeastern USA, indicating that this allele was not present in the USA samples. This neg-
ative result also suggested that, in these samples, there were different mutation(s) in the same
region that might correlate with resistance. To check for these alternative mutation(s), a 485 bp
gene fragment covering the domain II S4-S5 linker and IIS5 transmembrane segment of the V.
destructor VGSC (Fig 1) was PCR-amplified from genomic DNA, extracted from several indi-
viduals from all samples, and sequenced. This resulted in the identification of two new poly-
morphisms: a single point mutation, C to A, at nucleotide 3004 of the cDNA and the same C to
A substitution at 3004 together with G to A change at 3006 (as compared to the cDNA
sequence of V. destructor VGSC, Genbank accession No: KF771990). These mutations result in
amino acid substitutions at leucine 925; either L925M (CTG leucine to ATG methionine) or
L925I (CTG leucine to ATA isoleucine) in the VGSC of V. destructor. This suggests that alter-
native allelic variants of L925 –M925 and I925 –are responsible for pyrethroid resistance in the
USA samples, rather than the V925 allele previously reported in Europe (Fig 2A).
To determine the abundance and distribution of the 925M and 925I alleles within the USA
samples, and to establish if these mutations correlate with pyrethroid resistance, new Taq-
Man1 probes were designed to detect and discriminate these alleles in individual mites. In
order to achieve this, the TaqMan1 assay was multiplexed using three different custom
probes, each specific for one of the three possible allelic variants L925, M925 or I925, labelled
with VIC1, NED1 and 6-FAM™, respectively. An increase in VIC1 fluorescence would then
indicate the presence of the homozygous wild-type allele (leucine), while an increase in NED1
or 6-FAM™ fluorescence would indicate one of the mutant alleles, methionine or isoleucine.
Intermediate increases in the fluorescence of any two of the dyes would indicate a heterozygote
(L/M, L/I or M/I). After optimization, the TaqMan1 assay was able to routinely discriminate
among the six possible genotypes that could be generated by the three allelic variants (Fig 3).
Table 1 shows the results of the analysis of 257 individual adult mites from the 7 USA sam-
ple locations (6 from Florida and 1 from Georgia). They indicate a strong correlation (Spear-
man’s correlation coefficient ρ = 0.997, P< 0.0001) between survival of tau-fluvalinate
(Apistan) treatment and the presence of either the M925 or I925 mutant alleles. Only two of 91
mites (2%) surviving Apistan treatment were homozygous for the wild-type allele (L925), while
74 mites (81%) were homozygous for I925 and 9 mites (10%) were homozygous for M925. A
further 6 mites (7%) were heterozygous for the double mutant combination of M925/I925. For
the 166 mites from untreated chambers (ie. which did not undergo selection with Apistan) 91
(55%) were homozygous for the wild-type allele, L925, and only 57 (34%) were homozygous
for either of the mutated alleles. The remaining 18 (11%) were heterozygous for L925/I925 or
L925/M925, and since kdr/super-kdr is a recessive mechanism, these mites would be predicted
to show the susceptible phenotype.
Discussion
A single point mutation involving the substitution of leucine by valine at position 925 of the
VGSC (L925V) has been previously associated with resistance to tau-fluvalinate in samples of
V. destructor collected in Central/ Southern England [22] and in the Czech Republic [23]. Fur-
ther studies have shown that this mutation is widely distributed in V. destructor populations
across Europe and is highly correlated with recent treatments with synthetic pyrethroids (our
unpublished data). In contrast, we found no evidence for the L925V mutation within the
Mechanism of Pyrethroid Resistance in V. destructor in the USA
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samples from seven locations in Florida and Georgia despite significant resistance within these
samples following treatment with tau-fluvalinate. Instead, we identified two alternative allelic
variants at leucine 925, isoleucine and methionine (I925, M925) that correlate closely with
pyrethroid resistance in these populations. Neither of these substitutions has been reported
previously in V. destructor, although L925I has been identified and correlated with resistance
to pyrethroids in several other pest species, including Bemisia tabaci, Cimex lectularius, Rhipi-
cephalus microplus, Trialeurodes vaporariorum and Hyalella azteca [28–32]. A functional role
for L925I in conferring insensitivity (and hence resistance) to pyrethroids has also been dem-
onstrated by electrophysiological studies of Xenopus oocytes expressing L925I mutated chan-
nels [20, 33]. Although L925M is a novel mutation that has not been reported previously, its
similarity to the other two substitutions and selection within the treated samples suggest that it
too confers resistance to these compounds.
Leucine 925 is conserved across a wide range of species (Fig 2B). This amino acid is one of a
small number of residues, located within the proposed binding site for pyrethroids, that are
capable of mutating to give strong (so-called super-kdr) resistance, and also includes methio-
nine 918, threonine 929, leucine 932 and isoleucine 936 [20, 21]. Recent modelling of the V.
destructor VGSC further supports a role for these residues in the selective binding of the var-
roacides tau-fluvalinate and flumethrin, which have large, bulky acid groups that would appear
to fit better into the pyrethroid binding site of mite and tick (acari) VGSCs [24, 34]. It is, how-
ever, interesting that so far, we have only found substitutions at position 925 correlating with
the resistance to pyrethroids in V. destructor and as yet no variants at any of the other known
Fig 2. Alignment of nucleotide and/or amino acid sequences of the Voltage-Gated Sodium Channel fifth transmembrane segment (VGSC_IIS5). A-
V. destructor reference (Accession KF771990) and mutated sequences. B- Rhipicephalus microplus (Accession Q9XZC1), Ixodes scapularis (Accession
XP_002407119),Metaseiulus occidentalis (Accession XM_003741689), Tetranychus evansi (Accession ADK92428), Tetranychus urticae (Accession
ADB92110), Tetranychus cinnabarinus (Accession ADB92494), Sarcoptes scabiei var. canis (Accession ABL11237), Sarcoptes scabiei var.hominis
(Accession ABB05337), and Sarcoptes scabiei var.suis (Accession AAZ91446). Identical nucleotide and amino acid residues are shown as dots. Position
925 of the channel is boxed (M. domestica numbering EMBL accession N° X96668).
doi:10.1371/journal.pone.0155332.g002
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resistance positions. This implies that selection pressure favours modification of this residue in
V. destructor, although the reason for this is not clear and will be an interesting subject for fur-
ther investigation.
In our study, most (98%) of the V. destructor surviving treatment with tau-fluvalinate were
either homozygous for methionine (M/M), or isoleucine (I/I), or heterozygous (M/I) at postion
925 of the VGSC, but there were no L/M or L/I heterozygotes (Table 1). This is most likely a
consequence of the resistance trait being recessive at the discriminating concentration of tau-
fluvalinate present in Apistan1 strips since resistance to pyrethroids is known to be a recessive
trait [21]. This is important when addressing the dynamics of resistance in V. destructor with
its haplo/diploid reproductive mechanism and very high levels of inbreeding [1]. The strong
selection pressure imposed by a V. destructormanagement strategy based only on an intensive
and persistent use of pyrethroids would favour a very fast spread of resistant alleles amongst
populations. Since we see a very high frequency of mutant alleles in control non-treated mites
(Table 1), it would be expected that a fast increase in the rate of resistant mites per bee colony
would occur if they are subjected to treatment with pyrethroid-based acaricides. Our previous
study also suggested a reduced fitness of V. destructor with L925V, with the frequency of resis-
tant alleles decreasing to very low levels over several seasons when the selection pressure was
removed [22]. This feature has also been reported by others [35], with bee colonies showing a
10-fold reduction in the number of resistant mites over a period of three years.
Although the use of pyrethroids for V. destructor treatment has decreased in the last 10–15
years, the results presented here and those published previously [22, 35] suggest that it is possi-
ble to design control programs that include pyrethroids in rotation with other acaricide
Fig 3. Result of an allelic discrimination TaqMan1 assay for detection of mutations L925I and L925M in Varroa destructor VGSC. Scatter plot of
fluorescence data from: A- NED1 (M925 allele) vs VIC1 (L925 allele) andB- 6-FAM™ (I925 allele) vs VIC1 (L925 allele), showing the distribution of the six
possible genotypes given the three alleles present. L/L: Homozygous for Leucine, M/M: Homozygous for Methionine, I/I: Homozygous for Isoleucine, L/M:
Heterozygous for Leucine and Methionine, L/I: Heterozygous for Leucine and Isoleucine and M/I: Heterozygous for Methionine and Isoleucine. Values of X
and Y axes are final corrected fluorescence data.
doi:10.1371/journal.pone.0155332.g003
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treatments and specific cultural approaches to give effective control of the parasite. For the
long-term success of such programs, it is important that the ratio of susceptible/resistant mites
in a given apiary is known so that informed decisions regarding acaricide selection can be
made. In this context, effective monitoring tools such as the high throughput allelic discrimina-
tion assay reported here would be particularly useful. The multiplex assay allows several alleles
to be detected and monitored simultaneously and can be adapted according to the known vari-
ants within any particular region. These molecular-based tests are relatively cheap, very sensi-
tive and significantly faster than bioassays and very importantly do not require live material. A
more extensive monitoring program, widening the geographical scope of this study, would
help to map V. destructor resistance in a given area and this information would be useful to reg-
ulators, companies and other stakeholders and also to beekeepers who, armed with this knowl-
edge, would be able to judge better when they can use pyrethroid-based acaricides to control
this highly damaging parasite.
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